DXB.AX

Healthcare Biotechnology

Dimerix Limited

A$0.24

+0.02 +6.67% today

Price History

Not enough data

Key Stats

Market Cap

144.10M

Avg Volume

1.35M

EPS

-A$0.05

52W High

A$0.67

52W Low

A$0.16

Div. Yield

0.0%

Valuation

Forward P/E

-12.00

P/B Ratio

-9.60

P/S Ratio

22.68

EV/EBITDA

-3.39

EV/Revenue

18.75

PEG Ratio

0.72

Margins

Gross Margin 100.0%

Operating Margin (317.5%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Revenue Growth (YoY)

(20.0%)

Return on Assets

(29.4%)

Liquidity & Leverage

Current Ratio

3.82

Quick Ratio

3.75

Total Cash

16.15M

Total Debt

232,091

About

Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease; as well as DMX-652 for the treatment of acute kidney injury. The company is headquartered in Fitzroy, Australia.

dimerix.com